These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30400243)

  • 1. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
    Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
    Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities.
    Lu L; Hao K; Hong Y; Liu J; Zhu J; Jiang W; Zhu Z; Wang G; Peng Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.
    Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ
    Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Geng Y; Faber KN; de Meijer VE; Blokzijl H; Moshage H
    Hepatol Int; 2021 Feb; 15(1):21-35. PubMed ID: 33548031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes.
    Hong SH; Hong Y; Lee M; Keum BR; Kim GH
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
    Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
    Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
    Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
    Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease: Insights from sphingolipidomics.
    Montefusco DJ; Allegood JC; Spiegel S; Cowart LA
    Biochem Biophys Res Commun; 2018 Oct; 504(3):608-616. PubMed ID: 29778532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics in non-alcoholic fatty liver disease.
    Kartsoli S; Kostara CE; Tsimihodimos V; Bairaktari ET; Christodoulou DK
    World J Hepatol; 2020 Aug; 12(8):436-450. PubMed ID: 32952872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV; Diehl AM
    Gastroenterology; 2016 Jun; 150(8):1769-77. PubMed ID: 26928243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular glutathione in fatty liver in vitro models.
    Garcia MC; Amankwa-Sakyi M; Flynn TJ
    Toxicol In Vitro; 2011 Oct; 25(7):1501-6. PubMed ID: 21620948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.